Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study page now indicates that recruitment is closed ('No longer looking for participants') and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label was adjusted, and the page revision tag now shows v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T17:39:47.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision tag changed from v3.5.4 to v3.5.5, indicating an update to the site's revision metadata (an administrative UI/system change).
    Difference
    0.0%
    Check dated 2026-06-06T13:16:36.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a new page version. This change is a metadata update and does not alter visible content or functionality.
    Difference
    0.0%
    Check dated 2026-05-15T23:53:32.000Z thumbnail image
  5. Check
    63 days ago
    Change Detected
    Summary
    The page’s UI/version label was updated from Revision v3.5.2 to v3.5.3 on the bottom of the ClinicalTrials.gov record, without any changes to the underlying study details.
    Difference
    0.0%
    Check dated 2026-04-24T17:10:20.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2. Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T14:09:42.000Z thumbnail image
  7. Check
    84 days ago
    Change Detected
    Summary
    Two additional MeSH terms related to glomerulonephritis were added to the Additional Relevant MeSH Terms section, potentially improving searchability.
    Difference
    0.1%
    Check dated 2026-04-03T05:53:03.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.